Shreedhar Vijay
Chief Commercial Officer at Adamas Pharmaceuticals Inc
- Sold, on record
- $67k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jun 21, 2021
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- Adamas Pharmaceuticals IncChief Commercial Officer
Sales by reason
0
Routine
3
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Jun 21, 2021Plan not stated
Sold 3.6% of their holdings
$32k6,200 shares at $5.16
- Mar 22, 2021Plan not stated
Sold 0.6% of their holdings
$6k1,051 shares at $5.50
- Feb 1, 2021Plan not stated
Sold 4.5% of their holdings
$29k4,514 shares at $6.39
3 of 3
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | Nov 24, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Tendered | 186,786 | 0 | SEC | ||
| Nov 24, 2021 | Nov 24, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Returned to the companyStock Option (Right to Buy) | 185,000 | 0 | SEC | ||
| Nov 24, 2021 | Nov 24, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Awarded | 18,750 | 186,786 | SEC | ||
| Jun 21, 2021 | Jun 23, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Sold | 6,200 | $5.16 | $32k | 165,735 | SEC |
| Mar 22, 2021 | Mar 23, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Sold | 1,051 | $5.50 | $6k | 169,435 | SEC |
| Mar 2, 2021 | Mar 3, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Awarded | 75,000 | 170,486 | SEC | ||
| Feb 1, 2021 | Feb 1, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Sold | 4,514 | $6.39 | $29k | 95,486 | SEC |
| Mar 17, 2020 | Mar 19, 2020 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | AwardedStock Option (Right to Buy) | 47,500 | 47,500 | SEC | ||
| Mar 17, 2020 | Mar 19, 2020 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Awarded | 23,750 | 95,000 | SEC | ||
| Jun 7, 2019 | Jun 7, 2019 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | AwardedStock Option (Right to Buy) | 137,500 | 137,500 | SEC | ||
| Jun 7, 2019 | Jun 7, 2019 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Awarded | 68,750 | 68,750 | SEC |
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2021 | Jun 23, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Form 4 sale | 6,200 | $32k | 3.6% | Plan not stated | SEC |
| Mar 22, 2021 | Mar 23, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Form 4 sale | 1,051 | $6k | 0.6% | Plan not stated | SEC |
| Feb 1, 2021 | Feb 1, 2021 | Adamas Pharmaceuticals Inc | Chief Commercial Officer | Form 4 sale | 4,514 | $29k | 4.5% | Plan not stated | SEC |